Imad Aljabban

Plain English
Researchers analyzed registry data from over 58,000 patients with severe leg artery disease who had minimally invasive procedures, comparing those who took the drug cilostazol before surgery to those who did not. Patients who took cilostazol beforehand had a 44% lower risk of dying over five years and were less likely to lose a limb. These findings support testing cilostazol as a routine pre-operative treatment in this high-risk patient group.

Plain English
A gene-edited pig kidney was transplanted into a brain-dead human and kept functioning for a planned 61-day study using only standard approved anti-rejection drugs. The kidney maintained stable electrolyte balance and eliminated the need for dialysis, but antibody-mediated rejection emerged on day 33 and was reversed with plasma exchange and complement inhibition. The study shows a minimally modified pig kidney can sustain human-equivalent kidney function and identifies pre-existing immune cells reactive to pig tissue as a key obstacle to long-term success.

Plain English
Researchers studied how the human immune system reacts to a pig kidney transplant in a brain-dead human. They found that specific immune cells in the blood increased significantly, leading to rejection of the kidney by day 33 after the transplant. This research is important because it helps identify ways to improve the success of pig organ transplants in humans, potentially addressing the shortage of available human organs for transplantation.

Plain English
Using a national hospital database of 34 million patients, researchers measured how often solid organ transplant recipients develop aortic or iliac artery aneurysms. The overall rate was 0.48%, with heart and lung transplant recipients having higher rates than kidney or liver recipients. As transplant patients live longer, routine screening for these aneurysms in high-risk transplant groups becomes increasingly important.

Plain English
This review summarizes the current state of transplanting genetically modified pig hearts into humans, including two cases where patients survived 40 and 60 days. Hyperacute rejection has been largely solved through genetic engineering, but antibody-based and T cell-driven rejection remain major obstacles. The review outlines the experimental models being used to bridge the gap between animal studies and clinical trials.

Plain English
Pig organ transplantation into humans has advanced rapidly from animal studies to a handful of compassionate-use cases, with early results revealing key obstacles including antibody-mediated rejection, dangerous drops in platelet counts, and unknown long-term immune responses. As formal clinical trials approach, major decisions remain unresolved: which pig genetic modifications to use, how to suppress the immune system without leaving patients vulnerable to infection, and which patients are appropriate candidates. Addressing these challenges through coordinated, multidisciplinary work will determine whether xenotransplantation can realistically close the gap between organ supply and demand.

Plain English
Clinical research draws large volumes of blood from study subjects, but most blood collected for routine clinical tests goes unused and is discarded after analysis. In a 61-day xenotransplant experiment, researchers collected leftover clinical samples from the hospital lab twice weekly, recovering enough plasma to supply 62% of all research plasma needs without taking additional blood from the subject. This recycling approach can meaningfully reduce unnecessary blood loss in patients enrolled in intensive research studies.

Plain English
This study tracked how donor-reactive immune cells behaved during a 61-day pig-to-human decedent kidney transplant. Specific T cell clones that attack pig tissue were detected expanding in blood and the organ, and innate immune cells also contributed to rejection. The findings clarify the combined immune barriers that must be overcome before pig-to-human transplants can succeed in living patients.

Plain English
Researchers transplanted a pig kidney-thymus combination into a deceased human and tracked the immune response over 61 days. T cells from the recipient infiltrated the organ and specific clones expanded in blood, tissue, and lymph nodes around rejection events. This reveals that T cell-driven rejection of pig organs in humans closely mirrors what happens with human-to-human transplants, informing how future immunosuppression strategies must be designed.

Plain English
This study compared use of atherectomy (plaque-removal devices) and embolic protection devices in hospitals versus office-based labs for treating blocked leg arteries, using registry data from nearly 2,850 matched patient pairs. Embolic protection devices were used far less often in office labs (4.4%) than in hospitals (40%), yet immediate complications were similar between settings. Patients treated in office labs were 18% more likely to need a repeat procedure within two years, raising questions about long-term outcomes as more of these procedures shift outside hospitals.

Plain English
A technique called thoracoabdominal normothermic regional perfusion (TA-NRP) restores blood flow to organs in donors who die after cardiac arrest before the organs are removed, potentially improving their quality. In 22 such donors at a single center, organ use rates were high across all organ types, and kidney recipients had a lower rate of delayed graft function compared to standard cardiac-death donors. The results support TA-NRP as a promising procurement method, with comparable recipient outcomes to traditional donation approaches.

Plain English
In a mouse kidney transplant model, researchers discovered that accepted grafts rapidly develop specialized clusters of regulatory immune cells around blood vessels inside the organ itself, which they named TOLS. These structures form independently of lymph nodes, spleen, and thymus, and their molecular signature at one week after transplant can predict whether a graft will be accepted or rejected long-term. TOLS represent a previously unrecognized mechanism by which the transplanted organ actively promotes its own tolerance.

Plain English
A case report describes a patient who developed a rare surgical complication after receiving a simultaneous kidney and pancreas transplant: the large intestine became trapped in a gap created by the transplanted ureter and the abdominal wall. The bowel was freed and the ureteral connection was revised to close the space and prevent recurrence. Prompt surgical recognition avoided serious harm, and the case adds to the literature on post-transplant complications.

Plain English
A 16-year-old with opsoclonus myoclonus syndrome — a neurological condition involving abnormal eye movements, imbalance, and limb movements — was evaluated with whole-body MRI, which identified an ovarian teratoma as the cause. Surgical removal of the tumor led to complete resolution of neurological symptoms. The case supports using whole-body MRI in children with this condition to find hidden tumors without exposing them to radiation.

Plain English
Researchers built a web platform called STARGEO that lets users add standardized labels to the millions of genomic data samples stored in the public Gene Expression Omnibus database, which are otherwise hard to search due to inconsistent descriptions. Graduate students using the platform rapidly produced accurate, consistent annotations across diverse diseases, and the curated data were used to identify reliable genomic signatures of breast cancer. The tool makes a massive public genomics resource far more useful for large-scale disease research.

Plain English
In roundworm studies, researchers found that a mutation in the gene mrg-1 causes most reproductive cells to fail at pairing and aligning chromosomes during cell division, yet the worms still produce functional eggs because the body's quality control system eliminates most of the defective cells. Only when that quality control was disabled did the full extent of the chromosome-pairing failure become visible. This reveals that meiotic quality control can mask genetic defects, meaning similar mutations in other organisms may have been missed in past genetic screens.